Cancer epidemiology and prevention conferences

The spreading of cancer cells from the place where they formed to another part of the body. In this, cancer cells break aside from the original tumor, passes through the blood or lymphatic system, and form a new tumor in other organs or tissues of the body. The other name of metastasis is metastases

Cancer cells can spread locally by moving towards normal tissue. Metastatic cancer has a same name as primary cancer because if cancer cell spreads from breast cancer to lungs. Then the tumor formed in lungs, it is called as metastatic breast cancer.

Metastatic cancer, also called as stage IV cancer, it is the progressive form of cancer which spreads the malignant tumor from its original area to new sites of the body. Treating of metastatic cancer is more difficult than early-staged cancer. With increase in the popularity of disease and increase in life expectancy, there is also an increment in the R&D expenditure in the field of oncology. Although, several biopharmaceutical companies are trying to enter the market and are investing into oncology field to meet the increasing treatment needs of the metastatic cancer patients. Such companies continue effort for cost-effective cancer medicines with high capacity.

Market report:

  Overall metastatic cancer treatment market was worth $56.10 billion in 2017, and is anticipated to reach $99.245 billion by 2025. Raising popularity of cancer disease around the world and high unity medical needs of patients suffering from metastatic cancer are the drivers stimulating the growth of the metastatic cancer treatment market. In addition, increasing maintenance of biologics and biosimilars and ascending confirmation from regulatory bodies, are contributing to the increasing use of medicines for the treatment of metastatic cancer. The scope of the report is focus upon conducting a detailed study of the solutions associated with metastatic cancer treatment market, which involves drugs used in different therapeutic applications for cancer treatment such as chemotherapy, immunotherapy, radiotherapy, hormone therapy and others.

The purpose of the study is to gain a comprehensive view of the global metastatic cancer treatment market in terms of various factors changing it such as key market trends, competing and regulatory aspects of the market, scientific innovations into cancer fields, etc. The global metastatic cancer treatment market is divided into three different parts: by therapeutic indication, region and products.  The overall market value for metastatic cancer was estimated using these three different access and was validated with one another. These segments are further divided into several sub-divisions to ease the market estimation.

Sessions:

Cancer diagnosis and screening, cancer metastasis, cancer science, cancer cell biology, cancer genetics, tumor immunology, cancer case reports, epidemiology and prevention of cancer, cancer research, stages of cancer, types of cancer

 

 

Target Audience :

Academicians, healthcare professionals, oncologists, radiologists, academicians, chemotherapists, professors, cancer professionals, physicians, breast cancer surgeons, pathologists, medical practitioners, diagnostic laboratory professionals, genetic scientists, students, industry professionals

Tags :

cancer epidemiology and prevention conferences| cancer epidemiology conferences 2019| cancer prevention treatment| cancer stages| cancer prevention conferences Rome| cancer research Miami| cancer epidemiology 2019| cancer conferences USA| oncology research Miami

Quick Abstract Submission

Get In Touch

Venue

Crowne plaza, 950 NW 42nd Ave, Miami, FL 33126, USA

Call Us

+1-469-342-0402

Email Us

For Program Enquiry: contact@cancer-conferences.com
Sponsors/Exhibitions: cancerusa@cancer-conferences.com
General Queries: globalcancerconferences@gmail.com
Quick Contact